Loading clinical trials...
Loading clinical trials...
A Phase 2 Multi-Ascending Dose Trial to Assess the Efficacy, Tolerability and Pharmacokinetic Profile of Exendin (9-39) in Patients With Post-bariatric Hyperinsulinemic Hypoglycemia
Conditions
Interventions
Lyo avexitide
Liq avexitide
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
May 1, 2016
Primary Completion Date
June 1, 2017
Completion Date
June 1, 2017
Last Updated
November 13, 2020
Lead Sponsor
Tracey McLaughlin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions